Tech Company Inital Public Offerings
Invitae IPO
Invitae was acquired by . Shares were listed on 2/11/2015.
Transaction Overview
Company Name
Announced On
2/11/2015
Transaction Type
IPO
Amount
$101,600,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1400 16th St.
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Website
Email Address
Overview
Invitae Corporation (NYSE: NVTA), a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare in the United States, Canada, Israel, and internationally.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Randy Scott
Chief Marketing Officer
Robert Nussbaum
Browse more venture capital transactions:
Prev: 2/11/2015: NVBots venture capital transaction
Next: 2/11/2015: NEXTracker venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document funding rounds that are announced publicly. VC transactions on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs